Literature DB >> 22449766

Managing patients with dual diagnosis in psychiatric practice.

Michael Baigent1.   

Abstract

PURPOSE OF REVIEW: To focus on recent research that may influence clinical practice in relation to patients with dual diagnosis disorders. RECENT
FINDINGS: Harmful substance use is a heightened risk with bipolar disorder. Self-medication with substances of abuse for anxiety is linked with greater risk of developing anxiety disorders, particularly social anxiety disorder. Antisocial and schizotypal personality disorders were particularly linked with chronicity in substance use disorders. There are sex differences in responses to psychological approaches for dual disorders involving alcohol. Integrated dual diagnosis treatment for youth is not conclusive but shows promise. Online therapy is viable for adult patients with dual diagnosis. Structured interventions reduce the risk of opioid misuse amongst those with chronic pain, who are identified as at high risk.
SUMMARY: We have confirmation that clinicians should be particularly vigilant in monitoring for substance use problems early in anxiety disorders and mood disorders and that certain personality disorders are linked with substance use chronicity. Practitioners can incorporate specific therapy approaches for dual disorders that appear to have advantages over treatment as usual.

Entities:  

Mesh:

Year:  2012        PMID: 22449766     DOI: 10.1097/YCO.0b013e3283523d3d

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  12 in total

1.  Personality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings.

Authors:  Alvaro Vergés; Kristina M Jackson; Kathleen K Bucholz; Timothy J Trull; Sean P Lane; Kenneth J Sher
Journal:  J Abnorm Psychol       Date:  2014-10-13

2.  Utilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers.

Authors:  Patricia Cavazos-Rehg; Richard Grucza; Melissa J Krauss; Austin Smarsh; Nnenna Anako; Erin Kasson; Nina Kaiser; Samantha Sansone; Rachel Winograd; Laura J Bierut
Journal:  Drug Alcohol Depend       Date:  2019-10-28       Impact factor: 4.492

3.  Improving Medication Access within Integrated Treatment for Individuals with Co-Occurring Disorders in Substance Use Treatment Agencies.

Authors:  James H Ford; Arveen Kaur; Deepika Rao; Aaron Gilson; Daniel M Bolt; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  Implement Res Pract       Date:  2021-09-17

4.  Wait No Longer: Reducing Medication Wait-Times for Individuals with Co-Occurring Disorders.

Authors:  James H Ford; Deepika Rao; Aaron Gilson; Arveen Kaur; Helene Chokron Garneau; Lisa Saldana; Mark P McGovern
Journal:  J Dual Diagn       Date:  2022-04-07

Review 5.  Integrated treatment of substance use and psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley
Journal:  Soc Work Public Health       Date:  2013

6.  Sustainment of Integrated Care in Addiction Treatment Settings: Primary Outcomes From a Cluster-Randomized Controlled Trial.

Authors:  Helene Chokron Garneau; Mehret T Assefa; Booil Jo; James H Ford; Lisa Saldana; Mark P McGovern
Journal:  Psychiatr Serv       Date:  2021-08-04       Impact factor: 3.084

7.  Comorbidity and pattern of substance use in hospitalized psychiatric patients.

Authors:  Zahra Sepehrmanesh; Afshin Ahmadvand; Alireza Moraveji
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

Review 8.  Allostasis as a conceptual framework linking bipolar disorder and addiction.

Authors:  Mauro Pettorruso; Luisa De Risio; Marco Di Nicola; Giovanni Martinotti; Gianluigi Conte; Luigi Janiri
Journal:  Front Psychiatry       Date:  2014-12-03       Impact factor: 4.157

9.  Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.

Authors:  Angelo Giovanni Icro Maremmani; Silvia Bacciardi; Luca Rovai; Fabio Rugani; Enrico Massimetti; Denise Gazzarrini; Liliana Dell'Osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2014-12-12       Impact factor: 3.390

Review 10.  Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment.

Authors:  Robin C Wackernah; Matthew J Minnick; Peter Clapp
Journal:  Subst Abuse Rehabil       Date:  2014-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.